AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells

著者: Huiyu Li, Zhida Liu, Longchao Liu, Hongyi Zhang, Chuanhui Han, Luc Girard, Hyunsil Park, Anli Zhang, Chunbo Dong, Jianfeng Ye, Austin Rayford, Michael Peyton, Xiaoguang Li, Kimberley Avila, Xuezhi Cao, Shuiqing Hu, Md Maksudul Alam, Esra A. Akbay, Luisa M. Solis, Carmen Behrens, Sharia Hernández-Ruiz, Wei Lü, Ignacio I. Wistuba, John V. Heymach, Michael Chisamore, David Micklem, Hani Gabra, Gro Gausdal, James B. Lorens, Bo Li, Yang‐Xin Fu, John D. Minna, Rolf A. Brekken - Cell Reports Medicine 2022 被引用: 94

mutant NSCLC.